Product developments 16/17 - IntegraWatch® | Compliance Screening

IntegraWatch® | Compliance Screening is a curated database of individuals and organisations that have been identified as presenting compliance and integrity risks, categorised to 23 risk areas, which clients can screen their third parties against.

IntegraWatch® | Compliance Screening draws on publicly-available and proprietary-information sources to build a database of over four million data points.

FOCUS FOR 2017

New modern slavery and human trafficking statement requirements

The United Kingdom Modern Slavery Act transparency in supply chain provisions mean that all commercial organisations that supply goods or services, carry on a business (or part of a business) in the United Kingdom and have an annual turnover of above ₤36 million must submit a slavery and human trafficking statement each financial year. These statements must set out the steps the organisation has taken to ensure that slavery is not occurring in their own organisation or their supply chain. While the Act is not directive on the steps that must be taken, it is expected every business that meets the criteria (and many smaller businesses) will want to demonstrate some level of due diligence. In anticipation, IntegraWatch® | Compliance Screening has developed a dataset of entities that have been accused, or proven guilty, of engaging in modern slavery. Clients will be able to screen against the dataset (through the category ‘Watchlists and blacklists’) for preliminary and ongoing due diligence of suppliers.

New Policing and Crime Act 2017 introduces changes to the UK financial sanctions regime

The Policing and Crime Bill 2016 received royal assent in January 2017. Contained in that Act are increased custodial sentences and monetary penalties for non-compliance with financial sanctions, and alternative enforcement actions such as deferred prosecution agreements and serious crime prevention orders. IntegraWatch® | Compliance Screening keeps a record of all major sanctions by capturing information from the source, and enriches the database to include secondary identifiers and context to the sanction.

Supplier risks

The IntegraWatch® | Compliance Screening team will continue to enhance the database in a way that supports identification of compliance and integrity risks in the supply chain. The primary focus will be:

labour and human rights, covering violations of local health and safety legislation and workers’ rights, including wages, hours, anti-union practices and incidences of modern-day slavery (such as forced or bonded labour, child labour and human trafficking)
environmental issues, including breaches of legislation intended to safeguard the environment, poor emissions or waste management, and direct violations of environmental enforcement actions.

Sanctions, exclusions and export controls

IntegraWatch® | Compliance Screening will increase the cover of targeted export controls, sanctions and exclusions lists from outside of the core North American and European datasets.

New IntegraWatch® I Vessels Screening solution

This new database provides detailed information of a vessel and its associated parties, allowing businesses to make informed decisions based on the latest IHS Markit Ship Owner information and our sanctions and watchlists database.

Given the complex and closed nature of the maritime industry, standard due diligence on vessels and their related parties may not reveal ties to governments, entities, and individuals that are under sanctions. Specialist information is required to truly help businesses understand the network of owners and operators behind a vessel and this is not always easily available.

This is an extract from The Red Flag Group Annual Report 2016/17. To read the full report please click here

Additional sections of the Annual Report 2016/17 include:

Product developments 16/17 - IntegraCheck® | Integrity Due Diligence

IntegraCheck® I Integrity due diligence offers access to our knowledge, guidance and advice based on the cl...

Product developments 16/17 - Compliance Managed Services

The high workload expectations on compliance professionals leaves little time to manage resource intensive ...

Looking to build a perfect due diligence programme for your business?

Return to Home

Product developments 16/17 - IntegraWatch® | Compliance Screening

Previous Article

Next Article

Product developments 16/17 - IntegraWatch® | Compliance Screening

Previous Article

Next Article

Most Recent Articles

Identifying sanction-related risks can be daunting especially for entities with global operations and a large network of affiliates. More so, if the sanctions appear to be applicable or enforceable...

When considering the level of diligence, there tends to be a balance between the desire to look at the specific risks of that activity in detail and the need to build a process that is as efficient...

Although the formalisation of the discipline of risk management is relatively recent, the notion of enterprise-wide risk management appeared in the 1960s and was developed in the insurance field...

Compliance and legal teams are managing larger and more complex tasks beyond their traditional responsibilities. This is partly because of the changing landscape of the compliance industry...

Companies have a number of choices when deciding how to quantify and deal with the compliance risks related to their partners. For higher-risk partners, active due diligence exercises...

While many companies have realised that a ‘tick-the-box’ compliance model is not particularly effective, there is still a tendency to look at compliance areas through a very small lens...

Due to huge investments in the area of anti-corruption compliance, companies worldwide are now focused on protecting themselves from breaches of international corruption laws.

The role of compliance officers is changing – from being auditors to business advisors. More than ever before, compliance officers are being asked to partner with channel sales, procurement and other

Introducing change also needs to rely on a cohesive company culture. Before launching any new programme, compliance officers have to ensure that trust is there. If the company’s previous attempts...

Risk versus uncertainty. The first problem that most people encounter is that they are not always clear on what they mean by “risk”.

Which problem are we trying to fix? The main thing to think about is what are you trying to achieve from this initiative, and why?

In May of 2019, the Dutch Senate voted to adopt the initiative bill, championed by a member of the parliament Attje Kuiken (PvdA), requiring that all companies must declare that they will make efforts

The concept of including human rights in corporate risk management has broad implications for business across all sectors. One of the more immediate industries affected by this movement is the energy

Companies can set up shell companies with relative ease, and usually at a minimal cost. Shell companies are little more than a legal entity and often have no employees or specific business which...

Kicking off a third party due diligence programme can be a challenging and tedious undertaking due to various reasons including but not limited to lack of technical know-how and...

It’s all about making it easier to do the right thing and harder to do the wrong thing

The level at which known global organisations are failing to flag sanction breaches or are being fined for sanctions violations says a lot about the understanding of due diligence and screening in...

An appropriate preliminary solution when faced with hundreds or thousands of third parties, agents, resellers and distributors is to conduct watchlist screening, which reveals data on high-risk...

Nowadays, everyone is aware of the harm that a politically-exposed business partner or client can cause to an organisation – particularly in a place such as the Middle East, where the majority of...

Although regulations in Latin America have lacked in the past, it is catching up in healthcare due to the growing demand for healthcare products, including pharmaceuticals.